Chinese insulin manufacturer Gan & Lee Pharmaceuticals, which counts Qiming Venture Partners and Goldman Sachs among its investors, raised RMB2.5 billion ($354 million) through an A-share IPO.
The company sold 40.2 million shares at RMB63 apiece. The stock opened at RMB91.2 on June 29 and closed at the same price. as of midday on July 3, it was trading at RMB133.50. Qiming is the largest external...
Svolt Energy Technology, formerly the battery business unit of Chinese automaker Great Wall Motor, has raised a RMB3.5 billion ($542 million) Series A round featuring a string of government-linked investors.
Tiger Global Management has led a $100 million Series C round for India’s Infra.Market, valuing the construction materials marketplace at $1 billion.
Moore Threads, a Chinese chip designer established as recently as last October by a team from Nvidia, has closed two funding rounds amounting to several billion renminbi.
FountainVest Partners has agreed to acquire a majority stake in China-based CJ Rokin Logistics from Korea’s CJ Logistics for KRW733.8 billion ($661.3 million).